Hantavirus cruise ship outbreak lifts Moderna, Inovio and Novavax shares

Pharma and biotech names moved higher in early Monday trading as investors reacted to a hantavirus outbreak linked to the Dutch-flagged expedition ship MV Hondius. Moderna rose 7% premarket after citing preclinical hantavirus work, while Inovio gained 11% and Novavax added 5%. The WHO said the public health risk is low, and analysts cautioned the stock moves may be sentiment-driven rather than tied to meaningful revenue.